Take­da in­vests $760M+ in­to new plas­ma-de­rived ther­a­py man­u­fac­tur­ing site in Japan

The Japan­ese phar­ma gi­ant Take­da will be mak­ing a sig­nif­i­cant in­vest­ment close to home as it ex­pands its ca­pa­bil­i­ties in plas­ma ther­a­py man­u­fac­tur­ing.

Take­da an­nounced …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER